CTSH monthly performance report
Monthly CTSH research: returns, drawdown, relative strength, seasonality, and key stats.
CTSH monthly report
—
Key takeaways
- Cognizant (CTSH) closed August 2026 at $64.04, up 15.70% for the month and −10.71% over the trailing 12 months.
- Year-to-date, CTSH is −22.84%, underperforming the S&P 500 which has returned +12.82% YTD.
- The stock is trading +1.35% versus its 200-day moving average ($63.19), a bullish technical signal.
- Over the past three years, CTSH has underperformed the S&P 500 by −83.08%, with a relative strength index reading of 52.2.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Cognizant ended August 2026 at $64.04, posting a monthly return of +15.70%. The S&P 500 returned +2.99% over the same window, leaving relative performance at +12.71%.
The current quarter stands at +66.14% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +1.35% versus the 200-day moving average ($63.19).
Year-to-date, CTSH is −22.84% against SPY +12.82%, a gap of −35.66%. The stock is currently −26.42% below its 52-week high, with maximum 3-year drawdown at −57.30%.
| Period | CTSH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.44% | −0.23% | +0.67% |
| 1 Week | +3.51% | +0.47% | +3.03% |
| 1 Month | +15.70% | +2.99% | +12.71% |
| 3 Months | +20.47% | +2.52% | +17.95% |
| 6 Months | +4.42% | +10.99% | −6.57% |
| YTD | −22.84% | +12.82% | −35.66% |
| 12 Months | −10.71% | +18.56% | −29.27% |
| 3 Years | −9.32% | +73.76% | −83.08% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +39.42% |
| #2 | Aug 2026 | +19.17% |
| #3 | Jul 2024 | +11.54% |
| #4 | Nov 2023 | +9.30% |
| #5 | Oct 2025 | +9.10% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jun 2026 | −31.10% |
| #2 | Feb 2026 | −21.39% |
| #3 | Apr 2026 | −13.73% |
| #4 | Apr 2024 | −9.69% |
| #5 | Mar 2025 | −8.75% |
| Quarter | Return |
|---|---|
| Q2 2025 | −1.09% |
| Q3 2025 | −12.68% |
| Q4 2025 | +24.67% |
| Q1 2026 | −24.50% |
| Q2 2026 | −38.89% |
| Q3 2026 (QTD) | +66.14% |
| Year | Return |
|---|---|
| 2023 | +33.85% |
| 2024 | +1.56% |
| 2025 | +6.50% |
| 2026 | −23.35% |
| Metric | Value |
|---|---|
| 52-Week High | $87.03 (2026-01-14) |
| 52-Week Low | $37.08 (2026-06-30) |
| Current Price | $64.04 |
| 200-Day Moving Average | $63.19 |
| Price vs 200DMA | +1.35% |
| 3-Year Maximum Drawdown | −57.30% (2026-06-30) |
| Current Drawdown from 52W High | −26.42% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 52.2 |
| 3-Year Excess Return vs S&P 500 | −83.08% |
| RS Peak | 102.6 (Jan 2024) |
| RS Trough | 32.5 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CTSH's return for this report period?
CTSH returned +15.70% in the latest monthly window ending 2026-08-28.
Has CTSH outperformed SPY year to date?
YTD CTSH: −22.84% vs SPY: +12.82%.
What is CTSH's 12-month return?
−10.71% over the trailing 12 months.
Is CTSH above or below its 200-day moving average?
Price is +1.35% versus 200DMA ($63.19).
What is the maximum drawdown in the 3-year window?
−57.30% on 2026-06-30.